From theheart.org on Medscape

News from:

Transcatheter Cardiovascular Therapeutics (TCT) 2014

September 13 - 17, 2014; Washington, DC

Meeting Highlights at a Glance

Top News From TCT 2014: Slideshow Headlines include new data on transcatheter aortic-valve replacement, a real-world comparison of clopidogrel vs prasugrel in ACS, plus a sneak peek at how a bioabsorbable stent performs.

Conference News

TCT New Watchman Data Put Spotlight on Ischemic Stroke in AF
Heartwire from Medscape, September 23, 2014
TCT HEATed Debate: Stone, Stables Spar Over Best STEMI Strategy
Heartwire from Medscape, September 22, 2014
TCT Infarct Size Post-PCI Predictive of Mortality at One Year
Heartwire from Medscape, September 19, 2014
TCT No Brainer: Cap and Drape Reduce Radiation Exposure
Heartwire from Medscape, September 18, 2014
TCT TRANSLATE-ACS: No MACE Benefit With Prasugrel in ACS
Heartwire from Medscape, September 18, 2014
TCT Six Months of DAPT Offers SECURITY in Low-Risk PCI
Heartwire from Medscape, September 17, 2014
TCT PFO Closure Fails Anew in Migraine: PRIMA
Heartwire from Medscape, September 16, 2014
TCT SYMPLICITY-FLEX: RDN Misses in Mildly Hypertensive Patients
Heartwire from Medscape, September 16, 2014
TCT Female Interventionalists 'Very Rare,' Isolated
Heartwire from Medscape, September 16, 2014
TCT Light From BRIGHT: More Fuel for Bivalirudin-Heparin Debate
Heartwire from Medscape, September 15, 2014

TCT Reassuring Data on Use of DAPT and Anticoagulation
Heartwire from Medscape, September 15, 2014
TCT Drug-Eluting Balloon Falls Short of Stenting in DES ISR
Heartwire from Medscape, September 15, 2014
TCT ABSORB II Sneak Peek: Bioabsorbable Stent Is Safe, Effective
Heartwire from Medscape, September 14, 2014
TCT Dead or Treading Water: Experts Debate Renal Denervation
Heartwire from Medscape, September 14, 2014
TCT No Deaths With Mild/Moderate PVR: CoreValve Two-Year Data
Heartwire from Medscape, September 14, 2014
Alert TCT St Jude Issues Worldwide 'Pause' on Portico TAVR Implants
News Alerts, September 14, 2014
TCT TAVR vs Surgery in Intermediate-Risk Patients: OBSERVANT
Heartwire from Medscape, September 13, 2014
TCT Vascular-Closure Devices as Good as Hands-on in Angiography
Heartwire from Medscape, September 13, 2014
TCT Embolic Filter Reduces Cerebral Lesions During TAVI
Heartwire from Medscape, September 13, 2014
TCT PARTNER TAVR Deaths at Five Years: Sobering and Remarkable
Heartwire from Medscape, September 13, 2014

Perspectives from TCT

Is a Stroke Worse Than Death? Depends on Who You Ask
Robert A. Harrington, MD; David J. Cohen, MD
Antiplatelets and Anticoagulation: Balancing Risks and Benefits
Seth Bilazarian, MD; Nikolaus Sarafoff, MD
ISAR-TRIPLE: Six-Week vs Six-Month Clopidogrel in DES and AF
Nikolaus Sarafoff, MD
Renal Denervation: More Data, More Questions
Seth Bilazarian, MD; Steffen Desch, MD

Live Blog

News and Views from TCT 2014 Coverage of key advances and expert reactions as they happened at the meeting.

Previous Coverage